Veeva Systems Inc.

VEEV

Veeva Systems Inc. (VEEV) is a cloud software company that specializes in providing industry-specific solutions for the global life sciences sector. Established in 2007, Veeva offers cloud-based applications for clinical, regulatory, quality, commercial, and data management, helping pharmaceutical and biotech companies streamline operations, improve compliance, and accelerate product development. The company's platform is widely adopted for its ability to enhance efficiency and collaboration within the life sciences industry.

$242.00 -0.37 (-0.15%)
🚫 Veeva Systems Inc. does not pay dividends

Company News

2 Growth Stocks With More Room to Run to Buy Ahead of 2026
The Motley Fool • Prosper Junior Bakiny • December 2, 2025

The article highlights Netflix and Veeva Systems as promising growth stocks for investors, discussing their market positions, recent performance, and potential for future expansion in streaming and cloud computing sectors.

Stock Market Today: Dow Futures Gain, S&P 500 Slips Amid Mixed Trade—New Fortress Energy, Gap, Intuit In Focus (UPDATED)
Benzinga • Rishabh Mishra • November 21, 2025

U.S. stock futures showed mixed performance after Thursday's sell-off, with markets digesting a stronger-than-expected September jobs report and potential Federal Reserve interest rate decisions. Several companies reported earnings, with varied market reactions.

HealthEx appoints Jeremy Schwarz as Chief Commercial Officer
GlobeNewswire Inc. • Priyanka Agarwal And Anand Raghavan • November 19, 2025

HealthEx, a health data rights management platform, has appointed Jeremy Schwarz as Chief Commercial Officer to accelerate growth and drive patient-directed data exchange across healthcare ecosystems.

BlackRock Fund Dividend Reset Offers 9.2% Yield at a Discount
Investing.com • Brett Owens • September 17, 2025

BlackRock Health Sciences Term Trust (BMEZ) recently cut its dividend, but still offers a 9.2% monthly yield. The fund focuses on healthcare innovators that could benefit from potential policy changes, with top holdings in biotech and medical technology companies.

Reasons to Retain Veeva Systems (VEEV) in Your Portfolio Now - Zacks Investment Research
Zacks Investment Research • Zacks Investment Research • July 15, 2024

Veeva Systems is well-positioned for growth due to its strong product portfolio and strategic deals, but faces challenges from stiff competition and data security threats. The company's first-quarter fiscal 2025 performance and growth projections are positive, but rising costs and estimate trends are concerns.

Related Companies